<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR41">
 <label>41.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ferreira-Ramos</surname>
    <given-names>AS</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Eydoux</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Contreras</surname>
    <given-names>JM</given-names>
   </name>
   <name>
    <surname>Morice</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Quérat</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Gigante</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Pérez Pérez</surname>
    <given-names>M-J</given-names>
   </name>
   <name>
    <surname>Jung</surname>
    <given-names>M-L</given-names>
   </name>
   <name>
    <surname>Canard</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Guillemot</surname>
    <given-names>J-C</given-names>
   </name>
   <name>
    <surname>Decroly</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Coutard</surname>
    <given-names>B</given-names>
   </name>
  </person-group>
  <article-title>Approved drugs screening against the nsP1 capping enzyme of Venezuelan equine encephalitis virus using an immuno-based assay</article-title>
  <source>Antivir Res</source>
  <year>2019</year>
  <volume>163</volume>
  <fpage>59</fpage>
  <lpage>69</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2019.01.003</pub-id>
  <?supplied-pmid 30639438?>
  <pub-id pub-id-type="pmid">30639438</pub-id>
 </element-citation>
</ref>
